Zhengye Biotechnology (NASDAQ:ZYBT) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Zhengye Biotechnology (NASDAQ:ZYBT) to a hold rating in a research note issued to investors on Saturday morning.

Zhengye Biotechnology Price Performance

NASDAQ:ZYBT opened at $5.76 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.88 and a current ratio of 1.31. Zhengye Biotechnology has a 12-month low of $3.50 and a 12-month high of $14.30. The stock’s fifty day simple moving average is $6.57 and its 200-day simple moving average is $6.36.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.